Showing posts with label telepharmacy kiosk. Show all posts
Showing posts with label telepharmacy kiosk. Show all posts

Tuesday, February 23, 2010

PharmaTrust's Dispensing Machine Headed to the UK

PharmaTrust's MedCentre remote consultation and dispensing machine is likely headed to the UK, they've announced in a press release:
British Minister for Trade, Investment and Small Business, Lord Davies, said: “I am delighted that PharmaTrust has chosen the UK for a major expansion of its business. Its new prescription drug dispensing technology will revolutionize the way medicines are dispensed across the country and beyond.”
PharmaTrust sees the UK as "a key gateway to the European market." The CEO and co-founder, Don Waugh was invited to attend the Global Investment Conference hosted by British Prime Minister Gordon Brown. In the press release, he draws some parallels between PharmaTrust's machine and the first ATMs, introduced in London. Click here for more information about the PharmaTrust MedCentre.

Thursday, January 28, 2010

Ontario Hospitals will Dispense Drugs via PharmaTrust Kiosks

The PharmaTrust dispensing machine is set to be deployed in Canadian hospitals in the province of Ontario, according to an Ontario Hospital Association press release:

The OHA and PharmaTrust will collaborate on the installation of telepharmacy prescription-dispensing kiosks in hospitals across the province.

PharmaTrust MedCentre kiosks offer live video pharmacist counseling and quick and safe 24/7 access to prescription and over-the-counter medications, dispensed under the complete control of a pharmacist. The PharmaTrust MedCentre allows patients to simply insert their prescription, pick up the handset and interact live with a pharmacist who provides counselling via two-way video conferencing. The pharmacist is supported by integrated safety features to ensure prescription authenticity, accuracy and patient safety.

If you've been reading this blog for a while, you know that the kiosk was developed by Patient Care Automation Services, Inc with a grant from the National Research Council of Canada, and was trialed in Toronto's Sunnybrook Hospital.